Central blood pressure: current evidence and clinical importance

Area of Science:

• Cardiovascular medicine
• Hypertension research
• Clinical diagnostics

Background:

• Brachial artery pressure is a standard cardiovascular risk predictor.
• Systolic pressure varies across the arterial tree, with central (aortic) pressure typically lower than brachial.
• Individual variability in the brachial-central pressure difference is significant.

Purpose of the Study:

• To evaluate the prognostic value of central systolic pressure compared to brachial systolic pressure for cardiovascular events.
• To explore the implications of differential drug effects on central versus brachial pressure in hypertension management.
• To determine if a paradigm shift towards central pressure measurement is warranted for hypertension diagnosis and treatment.

Main Methods:

• Non-invasive measurement of brachial artery pressure using cuff and sphygmomanometer.
• Assessment of central systolic pressure, likely through validated transfer functions or other non-invasive techniques.
• Analysis of emerging evidence linking central pressure to cardiovascular outcomes.
• Review of anti-hypertensive drug effects on both brachial and central pressures.

Main Results:

• Central systolic pressure is suggested to be a better predictor of future cardiovascular events than brachial pressure.
• Anti-hypertensive medications can have differential impacts on central and brachial pressures.
• The difference between central and brachial systolic pressure is highly variable among individuals.

Conclusions:

• Measuring central systolic pressure may offer superior cardiovascular risk prediction over brachial artery pressure.
• Targeting central pressure in hypertension management could have significant clinical implications.
• Further direct evidence is required to confirm added benefits of selectively targeting central pressure in clinical practice.